Work

Underuse of oral anticoagulants in privately insured patients with atrial fibrillation: A population being targeted by the IMplementation of a randomized controlled trial to imProve treatment with oral AntiCoagulanTs in patients with Atrial Fibrillation (IMPACT-AFib)

Year: 2020

Type: article

Source: American Heart Journal

DOI: 10.1016/j.ahj.2020.07.012

Authors: Sana M. Al-Khatib, Sean D. Pokorney, Hussein R. Al-Khalidi, Kevin Haynes, Crystal Garcia, David Martin, Jennifer C. Goldsack, Thomas Harkins, Noelle M. Cocoros, Nancy D. Lin, Hana Lipowicz, Debbe McCall, Vinit Nair, Lauren Parlett, Cheryl N. McMahill-Walraven, Richard Platt, Christopher B. Granger

Institutions: Duke University, Duke Medical Center, Duke Clinical Research Institute, Carelon Research (United States), Harvard University, Harvard Pilgrim Health Care, United States Food and Drug Administration, Humana (United States), Aetna (United States)

Language: English

Topic: Atrial Fibrillation Management and Outcomes

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Health and Human Services, Pfizer, National Institutes of Health, U.S. Food and Drug Administration

Awards: G1156742305, G1642386491, G3777726589, G866023127

OpenAlex ID: W3045328587

FWCI: 2.429

Cites: 27

Cited by: 23

Related to: 10